On the other hand, sFlt-1 is a circulating anti-angiogenic protein that adheres to the receptor-binding domains of PlGF and vascular endothelial growth factor (VEGF), preventing their interaction with endothelial receptors and inducing endothelial dysfunction. This evidence concerns the gene PGF and endothelial dysfunction.